The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/− systemic therapy in locally advanced head and neck cancer

This publication has 29 references indexed in Scilit:

• Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion
  Journal of Clinical Oncology, 2019
• Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals
  Journal of Clinical Oncology, 2019
• Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database
  Oral Oncology, 2018
• Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States
  JAMA Oncology, 2016
• Elderly Patients With Squamous Cell Carcinoma of the Head and Neck and the Benefit of Multimodality Therapy
  The Oncologist, 2015
• Head and neck cancer in the elderly: An overview on the treatment modalities
  Cancer Treatment Reviews, 2009
• Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
  Journal of Clinical Oncology, 2008
• The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study
  European Archives of Oto-Rhino-Laryngology, 2006
• Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy
  Journal of Clinical Oncology, 2004
• A Matched Survival Analysis for Squamous Cell Carcinoma of the Head and Neck in the Elderly
  The Laryngoscope, 2003